TGFB1 and non-small cell lung carcinoma: In that study, treatment of human non-small cell lung cancer cells in vitro or as xenografts with M7824 was shown to clearly attenuate features of TGFβ1–mediated mesenchymalization, including a decrease in tumor mesenchymal marker expression and chemotherapy resistance of tumor cells.